Filing Details
- Accession Number:
- 0001104659-11-000851
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2011-01-07 18:22:03
- Reporting Period:
- 2010-12-17
- Filing Date:
- 2011-01-07
- Accepted Time:
- 2011-01-07 18:22:03
- Original Submission Date:
- 2010-12-17
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
881524 | Vivus Inc | VVUS | Pharmaceutical Preparations (2834) | 943136179 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1341526 | Wesley Day | 1172 Castro Street Mountain View CA 94040 | Vp, Clinical Development | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2010-12-17 | 70,600 | $9.54 | 16,800 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sale price reported in column 4 of Table I represents the weighted average sale price of the shares sold ranging from $9.49 to $9.63 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.